Tirzepatide, a recently approved medication, is creating considerable excitement within the healthcare community. It functions differently from existing diabetes therapies , targeting multiple receptors involved in blood regulation and satiety. Initial research have demonstrated remarkable efficacy in reducing blood glucose in individuals with adul